P1080: COMPARISON OF NIVOLUMAB 40 MG EFFICACY VERSUS 3 MG/KG IN PATIENTS WITH RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA

por Fedorova, L., Lepik, K., Mikhailova, N., Kondakova, E., Komarova, Y., Popova, M., Kotselyabina, P., Borzenkova, E., Baykov, V., Moiseev, I., Kulagin, A.
Publicado 2022

Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study

por Stanevich, O. V., Fomina, D. S., Bakulin, I. G., Galeev, S. I., Bakin, E. A., Belash, V. A., Kulikov, A. N., Lebedeva, A. A., Lioznov, D. A., Polushin, Yu. S., Shlyk, I. V., Vorobyev, E. A., Vorobyeva, S. V., Surovceva, T. V., Bakulina, N. V., Lysenko, M. A., Moiseev, I. S.
Publicado 2021

P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART CO...

por Basak, G., Peczynski, C., Koenecke, C., Terwel, S., Cabrerizo, Y., Penack, O., Moiseev, I., Schoemans, H., Fegueux, N., Potter, V., Zeerleder, S., Yakoub-Agha, I., Collin, M., Schanz, U., Dreger, P., Blaise, D., Besley, C., Glass, B., Mohty, M., Chabannon, C., Kuball, J., Snowden, J., Sureda, A., Kröger, N., Peric, Z.
Publicado 2022